Transgene (France) Market Value

TNG Stock  EUR 0.70  0.02  2.78%   
Transgene's market value is the price at which a share of Transgene trades on a public exchange. It measures the collective expectations of Transgene SA investors about its performance. Transgene is trading at 0.7 as of the 2nd of March 2025, a 2.78% down since the beginning of the trading day. The stock's open price was 0.72.
With this module, you can estimate the performance of a buy and hold strategy of Transgene SA and determine expected loss or profit from investing in Transgene over a given investment horizon. Check out Transgene Correlation, Transgene Volatility and Transgene Alpha and Beta module to complement your research on Transgene.
Symbol

Please note, there is a significant difference between Transgene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Transgene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Transgene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Transgene 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Transgene's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Transgene.
0.00
03/13/2023
No Change 0.00  0.0 
In 1 year 11 months and 22 days
03/02/2025
0.00
If you would invest  0.00  in Transgene on March 13, 2023 and sell it all today you would earn a total of 0.00 from holding Transgene SA or generate 0.0% return on investment in Transgene over 720 days. Transgene is related to or competes with Innate Pharma, Nanobiotix, Genfit, and AB Science. Transgene SA, a biotechnology company, designs, develops, and produces therapeutic vaccines and oncolytic viruses for th... More

Transgene Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Transgene's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Transgene SA upside and downside potential and time the market with a certain degree of confidence.

Transgene Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Transgene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Transgene's standard deviation. In reality, there are many statistical measures that can use Transgene historical prices to predict the future Transgene's volatility.
Hype
Prediction
LowEstimatedHigh
0.030.703.15
Details
Intrinsic
Valuation
LowRealHigh
0.030.603.05
Details
Naive
Forecast
LowNextHigh
0.010.693.13
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.690.710.73
Details

Transgene SA Backtested Returns

At this point, Transgene is extremely dangerous. Transgene SA owns Efficiency Ratio (i.e., Sharpe Ratio) of close to zero, which indicates the firm had a close to zero % return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Transgene SA, which you can use to evaluate the volatility of the company. Please validate Transgene's Risk Adjusted Performance of (0.02), variance of 6.1, and Coefficient Of Variation of (2,591) to confirm if the risk estimate we provide is consistent with the expected return of 0.006%. The entity has a beta of -0.41, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Transgene are expected to decrease at a much lower rate. During the bear market, Transgene is likely to outperform the market. Transgene SA right now has a risk of 2.45%. Please validate Transgene skewness, day typical price, and the relationship between the maximum drawdown and daily balance of power , to decide if Transgene will be following its existing price patterns.

Auto-correlation

    
  0.84  

Very good predictability

Transgene SA has very good predictability. Overlapping area represents the amount of predictability between Transgene time series from 13th of March 2023 to 7th of March 2024 and 7th of March 2024 to 2nd of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Transgene SA price movement. The serial correlation of 0.84 indicates that around 84.0% of current Transgene price fluctuation can be explain by its past prices.
Correlation Coefficient0.84
Spearman Rank Test0.85
Residual Average0.0
Price Variance0.05

Transgene SA lagged returns against current returns

Autocorrelation, which is Transgene stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Transgene's stock expected returns. We can calculate the autocorrelation of Transgene returns to help us make a trade decision. For example, suppose you find that Transgene has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Transgene regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Transgene stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Transgene stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Transgene stock over time.
   Current vs Lagged Prices   
       Timeline  

Transgene Lagged Returns

When evaluating Transgene's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Transgene stock have on its future price. Transgene autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Transgene autocorrelation shows the relationship between Transgene stock current value and its past values and can show if there is a momentum factor associated with investing in Transgene SA.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Transgene Stock

Transgene financial ratios help investors to determine whether Transgene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Transgene with respect to the benefits of owning Transgene security.